ArticleJTO clinical and research reports2023

Emerging EGFR-Mutated Subclones in a Patient With Metastatic ALK-Rearranged Lung Adenocarcinoma Treated With ALK-Targeted Therapy: A Case Report.

Jackson Ka Chun Leung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.